IBDEI0PZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11586,1,3,0)
 ;;=3^CRVO w/ NV,RIGHT eye                
 ;;^UTILITY(U,$J,358.3,11586,1,4,0)
 ;;=4^H34.8111
 ;;^UTILITY(U,$J,358.3,11586,2)
 ;;=^5138477
 ;;^UTILITY(U,$J,358.3,11587,0)
 ;;=H34.8121^^77^740^21
 ;;^UTILITY(U,$J,358.3,11587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11587,1,3,0)
 ;;=3^CRVO w/ NV,LEFT eye                 
 ;;^UTILITY(U,$J,358.3,11587,1,4,0)
 ;;=4^H34.8121
 ;;^UTILITY(U,$J,358.3,11587,2)
 ;;=^5138480
 ;;^UTILITY(U,$J,358.3,11588,0)
 ;;=H34.8110^^77^740^22
 ;;^UTILITY(U,$J,358.3,11588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11588,1,3,0)
 ;;=3^CRVO w/ CME,RIGHT eye               
 ;;^UTILITY(U,$J,358.3,11588,1,4,0)
 ;;=4^H34.8110
 ;;^UTILITY(U,$J,358.3,11588,2)
 ;;=^5138476
 ;;^UTILITY(U,$J,358.3,11589,0)
 ;;=H34.8120^^77^740^23
 ;;^UTILITY(U,$J,358.3,11589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11589,1,3,0)
 ;;=3^CRVO w/ CME,LEFT eye                
 ;;^UTILITY(U,$J,358.3,11589,1,4,0)
 ;;=4^H34.8120
 ;;^UTILITY(U,$J,358.3,11589,2)
 ;;=^5138479
 ;;^UTILITY(U,$J,358.3,11590,0)
 ;;=H21.1X1^^77^740^24
 ;;^UTILITY(U,$J,358.3,11590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11590,1,3,0)
 ;;=3^NVI/NVA/Rubeosis,RIGHT eye          
 ;;^UTILITY(U,$J,358.3,11590,1,4,0)
 ;;=4^H21.1X1
 ;;^UTILITY(U,$J,358.3,11590,2)
 ;;=^5005175
 ;;^UTILITY(U,$J,358.3,11591,0)
 ;;=H21.1X2^^77^740^25
 ;;^UTILITY(U,$J,358.3,11591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11591,1,3,0)
 ;;=3^NVI/NVA/Rubeosis,Left eye           
 ;;^UTILITY(U,$J,358.3,11591,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,11591,2)
 ;;=^5005176
 ;;^UTILITY(U,$J,358.3,11592,0)
 ;;=H35.711^^77^740^26
 ;;^UTILITY(U,$J,358.3,11592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11592,1,3,0)
 ;;=3^Central Serous Retinopathy,RIGHT eye
 ;;^UTILITY(U,$J,358.3,11592,1,4,0)
 ;;=4^H35.711
 ;;^UTILITY(U,$J,358.3,11592,2)
 ;;=^5005703
 ;;^UTILITY(U,$J,358.3,11593,0)
 ;;=H35.712^^77^740^27
 ;;^UTILITY(U,$J,358.3,11593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11593,1,3,0)
 ;;=3^Central Serous Retinopathy,LEFT eye 
 ;;^UTILITY(U,$J,358.3,11593,1,4,0)
 ;;=4^H35.712
 ;;^UTILITY(U,$J,358.3,11593,2)
 ;;=^5005704
 ;;^UTILITY(U,$J,358.3,11594,0)
 ;;=E11.9^^77^741^2
 ;;^UTILITY(U,$J,358.3,11594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11594,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,11594,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,11594,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,11595,0)
 ;;=E11.39^^77^741^1
 ;;^UTILITY(U,$J,358.3,11595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11595,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,11595,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,11595,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,11596,0)
 ;;=E10.9^^77^741^21
 ;;^UTILITY(U,$J,358.3,11596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11596,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,11596,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,11596,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,11597,0)
 ;;=E10.39^^77^741^20
 ;;^UTILITY(U,$J,358.3,11597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11597,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,11597,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,11597,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,11598,0)
 ;;=E10.3291^^77^741^22
 ;;^UTILITY(U,$J,358.3,11598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11598,1,3,0)
 ;;=3^DM Type 1 w/ Mild NPDR w/o Macula Edema,Right Eye
